期刊文献+

低脂联素血症——高血压心肌肥厚独立的危险因素 被引量:1

Hypoadiponectinemia——independent risk factor of hypertensive cardiac hypertrophy
下载PDF
导出
摘要 目的探讨脂联素及部分高血压危险因素与高血压心肌肥厚的关系,进一步明确低脂联素血症是否为高血压心肌肥厚的独立危险因素。方法①通过测量血压和心脏超声检查,把观察对象分为单纯高血压组(n=30)、高血压合并心肌肥厚组(n=19)和正常血压组(对照组,n=28)。②常规测量身高、体重,自动化生化分析仪测甘油三酯(TG)、总胆固醇(TCH)、低密度脂蛋白胆固醇(LDL)、高密度脂蛋白胆固醇(HDL)、空腹血糖(FPG),用固相酶联免疫吸附法测定空腹胰岛素(FIN),用双抗体夹心酶联免疫吸附法测定血清脂联素浓度。③计算体重指数(BMI)、胰岛素抵抗指数(HOMA-IR)、左心室质量指数(LVMI)。④对3组病例进行关于脂联素的方差分析,对所有观察对象各变量间进行相关分析。结果①与对照组比较,单纯高血压组、高血压合并心肌肥厚组血清脂联素浓度明显降低(P<0.05)。②相关分析表明:LVMI与收缩压(SBP)、舒张压(DBP)、FPG、FIN、HOMA-IR和TG呈明显的正相关,与脂联素呈明显的负相关(r=-0.431,P<0.01),与HDL、BMI、LDL和TCh相关性未达到统计学差异。FPG、FIN、HOMA-IR、LDL和TG虽与LVMI明显相关,但在控制脂联素和血压后,无明显相关性。结论①血压、脂联素、血脂、血糖、胰岛素和胰岛素抵抗与高血压心肌肥厚相关。②血脂、血糖、胰岛素和胰岛素抵抗不是高血压心肌肥厚独立的危险因素,而是通过血压、脂联素发挥作用。③高血压心肌肥厚主要与收缩压和脂联素相关,收缩压和低脂联素血症是高血压心肌肥厚独立的危险因素。 Objective To investigate the relationships between serum adiponectin concentration and hypertensive cardiac hypertrophy and that to other risk factors causing cardiac hypertrophy, so as to further demonstrate hypoadiponectinemia as an independent risk factor. Methods (1)Based on the results of BP and UCG, the subjects were divided into three groups: normotensive (control), essential hypertensive (EH) and essential hypertensive with cardiac hypertrophy (EH + LVH).(2)Body height and body mass were measured to calculate body surface. Triglycerides (TG), total cholesterol (TCh) , low- density lipoprotein ( LDL), high - density lipoprotein (HDL) and fast plasma glucose (FPG) were determined with automated biochemical analyser. Fasting insulin (FIN) was examined by insolubilized enzyme linked immunosorbent assay; adiponectins, by ABC - ELISA. (3)Body mass index ( BMI), homeostasis model assessment of insulin resistance ( HOMA - IR) and left ventricular mass index (LVMI) were calculated. (4)Tbe data were analysed by one - way ANOVA and for correlation of the variables with LVMI as the dependent variable. Results (1)The serum adiponectin concentration was lower in EH + LVH group than in the normotensive control and EH groups ( P 〈 0.01 ).(2)LVMI was found negatively correlated with adiponectin ( r = -0.43, P 〈0.01 ), and positively correlated with BP, FPG, FIN, HOMA - IR and TG ( P 〈 0.05 ). However, when adiponectin and BP were controlled,, there would no longer be any correlation between LVMI and FPG, FIN, HOMA - IR or TG ( P 〉 0.05 ). Conclusions (1)Hypertensive cardiac hypertrophy is correlated with BP, adiponectin, FPG, FIN, HOMA - IR and TG. (2)FPG, FIN, HOMA - IR and TG are not independent risk factors, they exert impacts on LVMI through SBP and adiponectin level. (3)Hence SBP and adiponectin lowering are the independent risk factors of hypertensive cardiac hypertrophy.
出处 《徐州医学院学报》 CAS 2008年第2期92-95,共4页 Acta Academiae Medicinae Xuzhou
关键词 脂联素 低脂联素血症 高血压 心肌肥厚 胰岛素抵抗 adiponectin hypoadiponectinemia hypertension cardiac hypertrophy insulin resistance
  • 相关文献

参考文献9

  • 1Garcia - Puig J, Ruilope LM, Luque M, et al. Glucose metabolism in patients with essential hypertension [ J ]. Am J Med, 2006, 119(4) :318 -326.
  • 2Davis CL, Kapuku G, Snieder H,et al. Insulin resistance syndrome and left ventricular mass in healthy young people [J]. Am J Med Sci, 2002, 324(2) :72 -75.
  • 3李小平,杨成悌,张灵,常鹏.高血压病患者血清脂联素水平的研究[J].中华心血管病杂志,2004,32(7):596-599. 被引量:37
  • 4Hong S J, Park CG, Seo HS, et al. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index [J]. Blood Press, 2004, 13(4) :236 - 242.
  • 5Liao Y, Takashima S, Maeda N, et al. Exacerbation of heart failure in adiponectin - deficient mice due to impaired regulation of AMPK and glucose metabolism [ J ]. Cardiovaac Res, 2005, 67 (4) :705 -713.
  • 6Mallamaci F, Zoccali C, Cuzzola F, et al. Adiponectin in essential hypertension [J]. J Nephrol, 2002, 15(5) :507 -511.
  • 7Fujioka D, Kawabata K, Saito Y, et al. Role of adiponectin receptors in endothelin - induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart [ J ]. Am J Physiol Heart Circ Physiol, 2006, 290(6) : H2409 - H2416.
  • 8Devereux RB, Casale PN, Kligfield P, et al. Performance of primary and derived M - mode echecardiographic measurements for detection of left ventrlcular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy [J]. Am J Cardiol, 1986, 57(15) :1388 - 1393.
  • 9Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta - cell function from fasting plasma glucose and insulin concentrations in man [J]. Diabetologia, 1985, 28(7) :412 -419.

二级参考文献15

  • 1Scherer PE, Willians S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995,270: 26746-26749.
  • 2Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo), 1996, 120: 803-812.
  • 3Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999, 257: 79-83.
  • 4Hanley AJ, Connelly PW, Harris SB, et al. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care, 2003, 26: 3219-3225.
  • 5Dzielinska Z, Januszewicz A, Wiecek A, et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res, 2003, 110: 365-369.
  • 6Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-KDa adipocyte complement -related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nat Acad Sci USA,2001,98:2005-2010.
  • 7Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acety1-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA, 2002, 99 : 16309-16313.
  • 8Yamauchi T, Kamon J, Mizokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 2002, 8: 1288-1295.
  • 9Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100: 2473-2476.
  • 10Ouchi N, Kihara S, Arita Y, et al. Adipocyte -derived plasma protein, adiponectin suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 103 : 1057-1063.

共引文献36

同被引文献13

  • 1樊清波,简立国,崔天祥,万大国,李莉.高血压病患者左室肥厚与血清脂联素水平的关系[J].中国老年学杂志,2005,25(9):1025-1026. 被引量:5
  • 2杨慧琴,栾姝蓉,程秀琴,唐维德.组织多普勒成像技术对高血压病左心室舒张功能的临床评价[J].心肺血管病杂志,2007,26(2):105-107. 被引量:4
  • 3Imatoh T,Miyazaki M,Momose Y,et al.Adiponectin levels associated with the development of hypertention,a prospective study.Hypertens Res,2008,31,229-233.
  • 4Shibata R,Ouchi N,Ito M,et al.Adiponectin-mediated modulation of hypertrophic signals in the heart.Nat Med,2004,10,1384-1389.
  • 5Hong SJ,Park CG,Seo HS,et al.Associations among plasma adiponectin,hypertension,left ventricular diastolic function and left ventricular mass index.Blood Press,2004,13,236-242.
  • 6Mancia G,De Backer G,Dominiczak A.2007 Guidelines for the management of arterial hypertension,The task Force for the management of arterial hypertension of the European societyof hypertension (ESR) and the European society of cardiology (ESC).J Hypertens,2007,25,1105-1187.
  • 7Mitsuhashi H,Yatsuya H,Tamakoshi K,et al.Adiponectin level and left ventricular hypertrophy in Japanese men.Hypertension,2007,49,1448-1454.
  • 8Okin PM,Devereux RB,Liu JE.Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass,the LIFE study.J Hum Hypertens,2004,6,403-409.
  • 9Liao Y,Ishikura F,Beppu S.Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice,necropsy validation.Am J Physiol Heart Circ Physiol,2002,5,H1703-H1708.
  • 10Fasshauer M,Klein J,Neumann S,et al.Adipenectin gene expression is inhibited by β2-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes.FEBS Lett,2001,507,142-146.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部